TOKYO, September 17, 2025 – LYFE Capital today announces that AP86 Co., Ltd., a special purpose company jointly owned by funds serviced by Advantage Partners (“AP”) and LYFE Capital’s affiliated funds, has successfully completed a tender offer (the “Tender Offer”) for the common shares issued by NIHON CHOUZAI Co., Ltd. (“NIHON CHOUZAI”; TSE Prime: 3341), a leading Japanese healthcare group that engages in operation of dispensing pharmacy chains, pharmaceutical manufacturing and healthcare staffing.
LYFE Capital intends to leverage its global healthcare domain knowledge and networks, in combination with AP’s extensive management improvement know-how accumulated in the past decades, to further accelerate NIHON CHOUZAI’s growth for achieving the mission “To give people the closest possible support.”
For further details regarding this Tender Offer, please refer to the “[Notice Regarding Completion of Tender Offer for Shares of NIHON CHOUZAI Co., Ltd. (Securities Code: 3341) by AP86 Co., Ltd., dated Sep 17, 2025.]”
<Overview of NIHON CHOUZAI Co., Ltd.>
Company Name: NIHON CHOUZAI Co., Ltd.
Representative: Kazunori Ogi, President & CEO
Location: 9F Tamachi Tower, 5-33-11, Shiba, Minato-ku, Tokyo 108-0014
Business: Dispensing Pharmacy Business, Pharmaceutical Manufacturing and Sales Business, Medical Professional Staffing and Placement Business
Website: https://www.nicho.co.jp/corporate/
About LYFE Capital
Founded in 2015, LYFE Capital is a pioneering healthcare investment platform led by a group of investment veterans and operators dedicated to identifying and supporting transformative companies across international markets. With 5 global offices in Asia and U.S., LYFE focus on investing in critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services, allowing them to grow significant and resilient revenues from global mature markets. The firm invests across pharmaceuticals, medical devices, diagnostics, and healthcare services, leveraging deep sector expertise, international networks, and strategic insights. LYFE Capital manages over $2.0 billion in assets and operates from offices in Menlo Park, Seoul, Singapore, Shanghai and Tokyo. For more information, please visit www.lyfecapital.com.
